Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)

ABSTRACT: Dipeptidyl peptidase-4 inhibitors (DPP-4Is) are one of the most frequently prescribed anti-diabetic agents in Japan, and they are often used in combination with insulin secretagogues, such as sulfonylureas and glinides. In the present study, we determined the efficacy and safety of the use...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetol Int
Auteurs principaux: Terawaki, Yuichi, Iwaya, Chikayo, Nomiyama, Takashi, Shimono, Dai, Horikawa, Tsuyoshi, Fujimura-Tanaka, Yuki, Shigeoka, Toru, Hamanoue, Nobuya, Motonaga, Ryoko, Tanabe, Makito, Yanase, Toshihiko, Kawanami, Daiji
Format: Artigo
Langue:Inglês
Publié: Springer Singapore 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7387390/
https://ncbi.nlm.nih.gov/pubmed/32802709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00426-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires